Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

<p class="Source---Synopsis"><strong>SYNOPSIS</strong>: Compared with enalapril, treatment with sacubitril/valsartan is more effective in reducing 30-day readmissions for any cause following discharge from congestive heart failure hospitalization.</p>

Influence of Sacubitril/Valsartan on 30-day Readmission After Heart Failure